Open AccessP563: A RANDOMIZED, DOUBLE‐BLIND, 2‐ARM, MULTICENTER, PH3 STUDY OF VENETOCLAX & ORAL AZACITIDINE VS. ORAL AZACITIDINE AS MAINTENANCE THERAPY FOR PTS WITH AML IN FIRST REMISSION AFTER INTENSIVE CHEMOTHERAPHY
Author(s) -
Ivanov V.,
Yeh S.P.,
Mayer J.,
Saini L.,
Unal A.,
Boyiadzis M.,
Hoffman D. M.,
Kang K.,
Addo S. N.,
Mendes W. L.,
Fathi A. T.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845140.40137.c7
Subject(s) - medicine , azacitidine , venetoclax , induction chemotherapy , maintenance therapy , chemotherapy , ven , gastroenterology , oncology , leukemia , surgery , chronic lymphocytic leukemia , biochemistry , gene expression , chemistry , computer security , computer science , dna methylation , gene